CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes

Journal

• Drug Metab. Dispos.

  Drug Metab. Dispos. 29 1480-, 2001